Nwk Group, Inc. Dexcom Inc Transaction History

Nwk Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $1.34 Million - $1.94 Million	15,786 New	15,786 $1.79 Million
Q4 2020 Feb 10, 2021	SELL	$78.0 - $104.5 $308,334 - $413,088	-3,953 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $13,657 - $16,151	143 Added 3.75%	3,953 $1.63 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $238,810 - $401,345	3,810 New	3,810 $1.55 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Nwk Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nwk Group, Inc. with notifications on news.